Replies to post #1366 on Conatus Pharmaceuticals Inc. (CNAT)

[Inoviorulez]

Yes I agree I hope they use MELD score as an approrpriate surrogate endpoint for LC patients. Those that decreased in MELD score by 2 or more saw a 40% reduced rate of death and liver transplant needed.